139 results
8-K
EX-10.1
LEXX
Lexaria Bioscience Corp
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
pursuant to the Company’s equity incentive plan, the Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any
424B5
8l7 0wv1yty
16 Feb 24
Prospectus supplement for primary offering
6:01am
8-K
EX-99.1
yvjr8k22aoj3iu3f
24 Jan 24
Regulation FD Disclosure
2:12pm
POS AM
2t0qoz0iwl31mp565i
24 Jan 24
Prospectus update (post-effective amendment)
1:33pm
S-8
EX-4.1
epvp1elxt3vs1hp
18 Jan 24
Registration of securities for employees
2:38pm
S-8
7xrjkki
18 Jan 24
Registration of securities for employees
2:38pm
S-8
5puzyon y1c7
18 Jan 24
Registration of securities for employees
2:38pm
8-K
EX-10.1
mzyl6lsd1c2t87w
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
424B5
74ms n00kotxxkz
2 Oct 23
Prospectus supplement for primary offering
4:06pm
424B4
0wmf 2v3afr
10 May 23
Prospectus supplement with pricing info
4:30pm
8-K
c4zsllwk7k2owi8 9k
10 May 23
Submission of Matters to a Vote of Security Holders
11:12am